Clinical trial
Comparative Efficacy and Cognitive Side-Effects of Ultrabrief Right Unilateral Electroconvulsive Therapy and Brief Pulse Bitemporal Electroconvulsive Therapy
NCT02238730 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Efficacy and Cognitive Side-Effects of Ultrabrief Right Unilateral Electroconvulsive Therapy and Brief Pulse Bitemporal Electroconvulsive Therapy
- Lead sponsor
- Kaiser Permanente
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- September 30, 2014
- Completion date
- February 15, 2017
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar disorder, depression, depressive disorder, major depressive disorder, treatment resistant depressive disorder